Message from the President

Toru Nakai
Representative Director, President
Toru Nakai

In 1919, our founder, Hisomu Ichinose, established Nippon Shinyaku with the aspiration to “make Japanese medicines with Japanese hands.” For over a century since then, under our business philosophy of “Helping People Lead Healthier, Happier Lives,” we have continued to address the evolving medical needs of the times and strive to create new value.

While modern medicine has made remarkable strides, numerous intractable and rare diseases still have no established effective treatments. I believe that bringing new hope to patients and their families struggling with such diseases is a crucial mission that Nippon Shinyaku must fulfill. Listening closely to the voices of patients and sincerely addressing their pressing needs, we advance our research and development with a primary focus on intractable and rare diseases. Concentrating our management resources on the field of intractable and rare diseases to deliver truly necessary treatment options represents both Nippon Shinyaku’s strength and its unique identity.

We have established the following as our Vision for 2035: “A global healthcare company from Kyoto creating various types of new ways of life for each person around the world.” This vision embodies the spirit of challenge that has been passed down since our founding, as well as our desire to stay close to each individual patient while continuing to deliver new value from Kyoto to the world. To achieve this, under our 7th Five-Year Medium-Term Management Plan, we are expanding our global reach, continuously strengthening our pipeline, and reinforcing our management foundations. By steadily driving these initiatives forward, we will create various types of “new ways of life” for as many patients as possible while achieving sustainable growth and enhancing our corporate value.

Going forward, we will continue to earn the trust of all our stakeholders, including patients and their families, healthcare professionals, shareholders, and investors, while fulfilling our responsibilities and pursuing growth for years to come. We would sincerely appreciate your continued understanding and support.

October 1, 2026

Representative Director, President

Toru Nakai